1
|
Wang S, Zhou T, Bian J, Li G, Zhang W, Chen S, Jiang Y. Clinical outcomes following surgical mitral valve plasty or replacement in patients with infectious endocarditis: A meta-analysis. Front Surg 2023; 9:1048036. [PMID: 36700028 PMCID: PMC9869952 DOI: 10.3389/fsurg.2022.1048036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Accepted: 12/01/2022] [Indexed: 01/09/2023] Open
Abstract
Background For degenerative mitral disease, more and more evidences support that mitral valve plasty (MVP) has much better clincial outcomes than mitral valve replacement (MVR). However, the advantages of MVP in patients suffering from infectious endocarditis (IE) are unclear. To evaluate the appropriateness of MVP in IE patients, we conducted this meta-analysis. Based on the difference between active and healed phase, we not only compared the result of patients with IE, but also identified the subgroup with active IE. Methods We systematically searched the clinical trials comparing clinical outcomes of MVP and MVR in patients suffering from IE. Relevant articles were searched from January 1, 2000 to March 18, 2021 in Pubmed and Cochrane Library. Studies were excluded if they were with Newcastle-Ottawa Scale (NOS) score less than 6 or lacking of direct comparisons between MVP and MVR. Results 23 studies were involved and 25,615 patients were included. Pooled analysis showed fewer adverse events and early or long-term death in the MVP group. However, more reoperations existed in this patient group. And the reinfection rate was close between two groups. Similar results were observed after identifying active IE subgroup, but there is no difference in the freedom from reoperation due to all-events. Conclusions Although limitimations exited in this study, patients suffering from IE can benefit from both MVP and MVR. For surgeons with consummate skills, MVP can be the preferred choice for suitable IE patients.
Collapse
Affiliation(s)
- Song Wang
- Department of Cardiovascular Surgery, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Nanjing, China,Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
| | - Ting Zhou
- Health Management Center, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Jinhui Bian
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
| | - Geng Li
- Department of Cardiovascular Surgery and Heart Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Wenjing Zhang
- Department of Ultrasound Medicine, The Second Afliated Hospital of Harbin Medical University, Harbin, China,Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China,Correspondence: Yefan Jiang Si Chen Wenjing Zhang
| | - Si Chen
- Department of Cardiovascular Surgery and Heart Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China,Correspondence: Yefan Jiang Si Chen Wenjing Zhang
| | - Yefan Jiang
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China,Department of Cardiovascular Surgery and Heart Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China,Correspondence: Yefan Jiang Si Chen Wenjing Zhang
| |
Collapse
|
2
|
Scheggi V, Olivotto I, Del Pace S, Zoppetti N, Brunetto A, Marchionni N, Cerillo A, Stefàno PL. Feasibility and outcome of mitral valve repair in patients with infective endocarditis. THE CARDIOTHORACIC SURGEON 2020. [DOI: 10.1186/s43057-020-00037-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Abstract
Background
Valve repair is the treatment of choice for native mitral valve regurgitation. The feasibility of repair when the defect is caused by acute infective endocarditis (IE) is debated. This study aims to compare the outcome of repair and replacement procedures, to report the rate of repair in a single surgical center, and to review the literature on this topic.
Results
We retrospectively analyzed 108 patients with native mitral IE, potentially eligible for surgical repair. Of these 108, 90 (83%) underwent surgery, and 18 were treated conservatively. Among the 90 surgical patients, 57 (63%) underwent valve replacement and 33 valve repair (37%). The mean follow-up duration was 3 years. The two primary endpoints were mortality and freedom from recurrent endocarditis. Secondary endpoints were the post-operative incidence of major adverse events (hospitalization for any cause, pacemaker implantation, new onset of atrial fibrillation, sternal dehiscence), left ventricular systolic function (LVSF), and valvular function at 1-year echocardiographic follow-up. All-cause mortality was lower for valve repair, although not significantly (p = 0.86), as well as nonfatal adverse events (p = 0.92) and relapse rate (p = 0.20) at 3 years. We did not find differences between the two groups at echocardiographic follow-up, neither for left ventricular systolic function (p = 0.22), nor for valvular continence (p = 0.28).
Conclusions
In our experience, the mid-term outcome of repair in IE is comparable to valve replacement and should be considered whenever possible, as in degenerative valve disease. The review of the literature supports this strategy.
Collapse
|
3
|
Okada Y, Nakai T, Muro T, Ito H, Shomura Y. Mitral valve repair for infective endocarditis: Kobe experience. Asian Cardiovasc Thorac Ann 2020; 28:384-389. [PMID: 32757655 PMCID: PMC7818674 DOI: 10.1177/0218492320947586] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Objectives We retrospectively analyzed our experience of mitral valve repair for native
mitral valve endocarditis in a single institution. Methods From January 1991 to October 2011, 171 consecutive patients underwent surgery
for infective endocarditis. Of these, 147 (86%) had mitral valve repair. At
the time of surgery, 98 patients had healed (group A) and 49 had active
infective endocarditis (group B). Repair procedures included resection of
all infected tissue and thick restricted post-infection tissue, leaflet and
annulus reconstruction with treated autologous pericardium, chordal
reconstruction with polytetrafluoroethylene sutures, and ring annuloplasty
if necessary. Fifty-two (35%) patients required concomitant procedures. The
study endpoints were overall survival, freedom from reoperation, and freedom
from valve-related events. The median follow-up was 78 months. Results There was one hospital death (hospital mortality 0.7%). Survival at 10 years
was 88.5% ± 3.5% with no significant difference between the two groups
(p = 0.052). Early reoperation was required in 4
patients in group B due to persistent infection or procedure failure.
Freedom from reoperation at 5 years was 99% ± 1.0% in group A and
89.6 ± 4.0% in group B (p = 0.024). Event-free survival at
10 years was 79.3% ± 4.8% (group A: 83.4% ± 5.9%, group B: 72.6% ± 6.9%,
p = 0.010). Conclusions Mitral valve repair was highly successful using autologous pericardium,
chordal reconstruction, and ring annuloplasty if required. Long-term results
were acceptable in terms survival, freedom from reoperation, and event-free
survival. Mitral valve repair is recommended for mitral infective
endocarditis in most patients.
Collapse
Affiliation(s)
| | - Takeo Nakai
- Heart Valve Center, Midori Hospital, Kobe, Japan
| | - Takashi Muro
- Heart Valve Center, Midori Hospital, Kobe, Japan
| | - Hisato Ito
- Department Thoracic and Cardiovascular Surgery, Mie University School of Medicine, Tsu, Mie, Japan
| | - Yu Shomura
- Department Thoracic and Cardiovascular Surgery, Mie University School of Medicine, Tsu, Mie, Japan
| |
Collapse
|
4
|
Tepsuwan T, Rimsukcharoenchai C, Tantraworasin A, Taksaudom N, Woragidpoonpol S, Chuaratanaphong S, Nawarawong W. Comparison between mitral valve repair and replacement in active infective endocarditis. Gen Thorac Cardiovasc Surg 2019; 67:1030-1037. [DOI: 10.1007/s11748-019-01132-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2019] [Accepted: 04/25/2019] [Indexed: 10/26/2022]
|